Skip to main content

Table 1 Participant characteristics

From: Monitoring activity of hip injury patients (MoHIP): a sub-study of the World Hip Trauma Evaluation observational cohort study

  Recruited Cohort (n = 29 unless otherwise stated)n = 13 (activity monitor group)
Age, median [IQR] 76 [71, 82]77 [71, 84]
Women, n (%) 18 (64.3)12 (92.3)
Pre-admission residence, n (%)Own home 28 (100)13 (100)
Nursing home 0 (0)0 (0)
Pre-fracture mobilityFreely mobile without aids 22 (78.6)9 (69.2)
Mobile outdoors with one aid 4 (14.3)3 (23.1)
Mobile outdoors with 2 aids or a frame 1 (3.6)0 (0)
Some indoor mobility, only mobilise outdoors with help 1 (3.6)1 (7.7)
Type of fracture, n (%)Intracapsular 19 (67.9)9 (69.27)
Extracapsular 8 (28.6)4 (30.7)
Sub-trochanteric 1 (3.6)0 (0)
Type of surgery, n (%)Arthroplasty—total hip replacement 10 (35.7)5 (38.4)
Hemiarthroplasty 6 (21.4)2 (15.4)
FixationSliding hip screw6 (21.4)2 (15.4)
Cannulated screw2 (7.1)2 (15.4)
IM nail (long)4 (14.3)2 (15.4)
Type of anaesthesia, n (%)General 20 (71.4)11 (84.6)
Intra-operative sedation 9 (32.1)2 (15.4)
Intra-operative nerve block 11 (39.3)7 (53.8)
Spinal 10 (35.7)3 (23.1)
Medical history, n (%)Myocardial infarction 2 (7.1)2 (15.4)
Heart failure 1 (3.6)1 (7.7)
Stroke/TIA 2 (7.1)2 (15.4)
Diabetes 0 (0)0 (0)
Renal dysfunction (moderate to severe) 0 (0)0 (0)
Respiratory disease 5 (18.5)3 (23.1)
Rheumatoid arthritis or connective tissue disease 3 (10.7)2 (15.4)
Malignancy 10 (35.7)4 (30.8)
ASA Score, n (%)I 3 (10.7)1 (7.7)
II 12 (42.9)5 (38.5)
III 6 (21.4)2 (15.4)
IV 5 (17.9)3 (23.1)
V 0 (0)0 (0)
Unknown 2 (3.7)2 (15.4)
Other clinical factorsReceipt community physiotherapy in 1st month 8 (28.6)*3 (23.1)
Pain/discomfort (baseline)*None13 (48.1)6 (46.2)
Slight6 (22.2)4 (30.8)
Moderate8 (29.6)3 (23.1)
Severe0 (0)0 (0)
Extreme0 (0)0 (0)
Anxiety/depression (baseline)*None19 (70.4)11 (84.6)
Slight6 (22.2)2 (15.4)
Moderate1 (3.7)0 (0)
Severe0 (0)0 (0)
Extreme1 (3.7)0 (0)
  1. ASA Score American Society of Anesthesiologists physical classification system score [23]
  2. *Data available for 28 participants